Community Empowerment, Vascular Risk, and ADRD Disparities: Translating Research to Public Policy
社区赋权、血管风险和 ADRD 差异:将研究转化为公共政策
基本信息
- 批准号:10723077
- 负责人:
- 金额:$ 12.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdultAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanAreaAwardBlack PopulationsBlack raceBlood VesselsCaliforniaCardiovascular DiseasesCensusesCharacteristicsClinicalCollaborationsCommunitiesCommunity SurveysCountyDataData ScienceDepressed moodDeteriorationDevelopmentDisparityEconomic FactorsEconomicsElderlyEnsureEventExclusionFacultyFoundationsFutureGoalsHealth Care CostsHealth PolicyHealth and Retirement StudyHousingIncidenceInfrastructureInstitutionInterventionInvestmentsJointsKnowledgeLeadLinkLow incomeMachine LearningMediatingMediatorMedicareMedicare claimMentorsMentorshipMinorityModelingNeighborhoodsPatternPhasePoliciesPolitical FactorPoliticsPopulationPopulation Attributable RisksPositioning AttributePrevalencePreventionPublic HealthPublic PolicyRaceRacial SegregationReasons for Geographic And Racial Differences in StrokeRelative RisksResearchResearch PersonnelResourcesRiskRisk EstimateRisk FactorsRoleSamplingSan FranciscoScienceSocial EnvironmentStroke BeltStructural RacismSurveysTrainingTranslatingUniversity resourcesVariantbeneficiaryblack/white disparityburden of illnesscardiovascular disorder epidemiologycardiovascular disorder riskcardiovascular effectscohortcommunity-level factorcultural competencedementia riskdemographicsdisparity reductioneconomic indicatorempowermentinnovationmarginalizationmortalityneighborhood disadvantagepolicy implicationpreventracial disparityresidencescale upsegregationskillssocioeconomicssuccesssystemic barrier
项目摘要
PROJECT SUMMARY ABSTRACT
By 2050, racial disparities will persist among the projected 11 million adults with Alzheimer’s Disease and
Related Dementias (AD/ADRD). Prior research links racial segregation to AD/ADRD, highlighting the
need for structural solutions to mitigate the racially patterned cardiovascular disease (CVD) burden that
accelerates AD/ADRD onset. Economic disinvestment prevents Black, poor, and Stroke Belt
neighborhoods from investing in their local infrastructure, while systemic barriers lead to political
disenfranchisement among the very historically excluded groups who would benefit most from effective
health policy. However, it is not known how disinvestment and disenfranchisement—factors produced by
structural racism—contribute to AD/ADRD disparities via excess CVD risk.
This proposed K99/R00 harnesses the Reasons for Geographic and Racial Differences in Stroke
(REGARDS) Study, Health and Retirement Study (HRS), and administrative claims from Medicare
Beneficiaries. For my K99 phase, I will identify indicators of economic disinvestment and political
disenfranchisement that worsen AD/ADRD trajectories and widen racial disparities in REGARDS and
HRS. Then I will use these results to calculate the population attributable fraction of disinvestment and
disenfranchisement on AD/ADRD among Medicare Beneficiaries. During my R00 phase, I will analyze the
mediating role of CVD in associations of disinvestment or disenfranchisement and incident AD/ADRD in
Medicare claims. Finally, I will utilize the CVD Policy Model to forecast nationwide community
empowerment policies to reduce CVD risk factors for AD/ADRD up to three decades in the future.
Building upon my foundation of data science, causal inference, and CVD epidemiology, my training plan
consists of new knowledge domains: 1) AD/ADRD science, 2) spatial modeling, 3) Medicare claims, and
4) estimation of public health impact attainable with structural interventions.
Based at the richly resourced University of California, San Francisco, I have assembled a team of
distinguished mentors with the ideal combination of expertise to facilitate my success. The integrated
science, training, mentorship, and professional development will prepare me for a faculty position at an
R1 institution. My longterm goal is to become an independent investigator who develops interventions and
policies to prevent AD/ADRD among low-income, Black, and Stroke Belt communities.
项目摘要摘要
到2050年,预计有1100万阿尔茨海默氏病的成年人将继续存在种族差异
相关痴呆症(AD/ADRD)。先前的研究将种族隔离连接到广告/ADRD,突出显示
需要结构性解决方案来减轻种族歧视的心血管疾病(CVD)Burnen
加速AD/ADRD发作。经济投资可以防止黑色,贫穷和中风带
从投资本地基础设施的社区,而系统性障碍则导致政治
在历史上排斥的团体中,剥夺了公民权,他们将从有效中受益最大
卫生政策。但是,尚不清楚如何进行宣传和剥夺权利 - 由
结构性种族主义 - 通过超过CVD风险归因于AD/ADRD差异。
这提出了k99/r00,这利用了中风的地理和种族差异的原因
(有关)研究,健康和退休研究(HRS)以及Medicare的行政主张
受益人。对于我的K99阶段,我将确定经济投资和政治投资的指标
剥夺广告/ADD轨迹和广泛的种族差异的剥夺权利
HRS。然后,我将使用这些结果来计算投资投资的可归因于可归因于
在医疗保险受益人中,对AD/ADRD的剥夺权利。在我的R00阶段,我将分析
CVD在撤销或剥夺合法性和事件AD/ADRD协会中的中介作用
Medicare主张。最后,我将利用CVD政策模型来预测全国社区
授权政策可将AD/ADRD的CVD风险因素降低到未来的三十年。
在我的数据科学,因果推理和CVD流行病学的基础上,我的培训计划
由新知识领域组成:1)AD/ADRD科学,2)空间建模,3)Medicare主张和
4)通过结构性干预措施可以估算公共卫生影响。
我在加利福尼亚大学旧金山的富裕分校的总部集会了一个团队
具有理想的专家组合以促进我的成功。集成
科学,培训,心态和专业发展将为我做好准备
R1机构。我的长期目标是成为制定干预措施和的独立调查员
在低收入,黑色和中风带社区中预防广告/ADRD的政策。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.
非药物治疗对低风险美国成年人 1 期高血压的预计影响。
- DOI:10.1101/2023.12.26.23300563
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Sims,KendraD;Wei,PengxiaoCarol;Penko,JoanneM;Hennessy,Susan;Coxson,PamelaG;Mukand,NitaH;Bellows,BrandonK;Kazi,DhruvS;Zhang,Yiyi;Boylan,Ross;Moran,AndrewE;Bibbins-Domingo,Kirsten
- 通讯作者:Bibbins-Domingo,Kirsten
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kendra D Sims其他文献
Associations of Everyday and Lifetime Experiences of Discrimination With Willingness to Undergo Alzheimer Disease Predictive Testing.
日常和一生的歧视经历与接受阿尔茨海默病预测测试的意愿之间的关联。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:9.9
- 作者:
Tanisha G. Hill;Minhyuk Choi;P. Buto;Silvia Miramontes;Marilyn D Thomas;Yulin Yang;Min Hee Kim;Kendra D Sims;M. M. Glymour - 通讯作者:
M. M. Glymour
Association of Cancer History with Structural Brain Aging Markers of Alzheimer's Disease and Dementia Risk
癌症史与阿尔茨海默病和痴呆风险的结构性脑老化标志物的关联
- DOI:
10.1101/2023.02.19.23286154 - 发表时间:
2023 - 期刊:
- 影响因子:5.7
- 作者:
J. Wang;Kendra D Sims;S. Ackley;R. Chen;L. Kobayashi;E. Hayes‐Larson;E. Mayeda;P. Buto;S. Zimmerman;R. E. Graff;M. M. Glymour - 通讯作者:
M. M. Glymour
Abstract 055: Neighborhood-Wide Association Study Of Hypertension In The Health And Retirement Study
摘要 055:健康和退休研究中高血压的全社区协会研究
- DOI:
10.1161/circ.145.suppl_1.055 - 发表时间:
2022 - 期刊:
- 影响因子:37.8
- 作者:
Kendra D Sims;P. Hystad;G. D. Batty;E. Smit;Jessina C. McGregor;M. Odden - 通讯作者:
M. Odden
Kendra D Sims的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 12.22万 - 项目类别:
Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
- 批准号:
10644490 - 财政年份:2023
- 资助金额:
$ 12.22万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 12.22万 - 项目类别:
Heart-brain MRI for the evaluation of hemodynamic coupling in aging and Alzheimer's disease
心脑 MRI 用于评估衰老和阿尔茨海默氏病的血流动力学耦合
- 批准号:
10571411 - 财政年份:2023
- 资助金额:
$ 12.22万 - 项目类别: